Speaker Profile

Chief Executive Officer, LevitasBio, Inc.

Mr. Pieprzyk, is a highly technical life science executive that brings deep knowledge of the Life Science Industry, with extensive experience in single-cell genomics, next-generation sequencing, gene expression, microfluidics, and digital PCR applications. He is also well versed in company development and funding, from inception through IPO process and public company operations. His combined background and experience position him well to continue leading LevitasBio in our mission to revolutionize cellular analysis.

Clinical & Research Tools Showcase:

LevitasBio is advancing science and human health by providing researchers with a new and powerful tool for cellular processing and characterization. Our disruptive levitation technology overcomes current technological limitations by providing a gentle, label-free method of purifying, enriching and characterizing specific cell populations.

Maximizing Cellular Insights with Novel Levitation Technology
Sample preparation is an essential component of every workflow, yet remains a key bottleneck hindering high quality research outcomes. LevitasBio is revolutionizing sample prep with the world’s first gentle, label-free solution for cellular processing and characterization.

 Session Abstract – PMWC 2022 Silicon Valley

Track 6, June 28-30

The PMWC 2022 Clinical & Research Tools Showcase will provide a 15-minute time slot for selected companies in this space. The Clinical & Research Tools is a showcase for innovative technologies that are used for the analysis of genetic variation and function, helping to advance breakthroughs in genetic health, rare disease conditions on individuals of all ages, complex diseases and cancer care. Next-generation sequencing (NGS) and microarray technologies empower rapidly evolving genomic revolution.